554 related articles for article (PubMed ID: 24155219)
1. Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling.
Hasegawa T; Yashiro M; Nishii T; Matsuoka J; Fuyuhiro Y; Morisaki T; Fukuoka T; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Int J Cancer; 2014 Apr; 134(8):1785-95. PubMed ID: 24155219
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells.
Fuyuhiro Y; Yashiro M; Noda S; Kashiwagi S; Matsuoka J; Doi Y; Kato Y; Hasegawa T; Sawada T; Hirakawa K
Br J Cancer; 2011 Sep; 105(7):996-1001. PubMed ID: 21863023
[TBL] [Abstract][Full Text] [Related]
3. Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma.
Nishii T; Yashiro M; Shinto O; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2009 Aug; 100(8):1397-402. PubMed ID: 19493275
[TBL] [Abstract][Full Text] [Related]
4. Activation of Transforming Growth Factor Beta 1 Signaling in Gastric Cancer-associated Fibroblasts Increases Their Motility, via Expression of Rhomboid 5 Homolog 2, and Ability to Induce Invasiveness of Gastric Cancer Cells.
Ishimoto T; Miyake K; Nandi T; Yashiro M; Onishi N; Huang KK; Lin SJ; Kalpana R; Tay ST; Suzuki Y; Cho BC; Kuroda D; Arima K; Izumi D; Iwatsuki M; Baba Y; Oki E; Watanabe M; Saya H; Hirakawa K; Baba H; Tan P
Gastroenterology; 2017 Jul; 153(1):191-204.e16. PubMed ID: 28390866
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular targeting compound as K-samII/FGF-R2 phosphorylation inhibitor, Ki23057, for Scirrhous gastric cancer.
Nakamura K; Yashiro M; Matsuoka T; Tendo M; Shimizu T; Miwa A; Hirakawa K
Gastroenterology; 2006 Nov; 131(5):1530-41. PubMed ID: 17101326
[TBL] [Abstract][Full Text] [Related]
6. Fibrosis in the peritoneum induced by scirrhous gastric cancer cells may act as "soil" for peritoneal dissemination.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Cancer; 1996 Apr; 77(8 Suppl):1668-75. PubMed ID: 8608560
[TBL] [Abstract][Full Text] [Related]
7. Peritoneal metastatic model for human scirrhous gastric carcinoma in nude mice.
Yashiro M; Chung YS; Nishimura S; Inoue T; Sowa M
Clin Exp Metastasis; 1996 Jan; 14(1):43-54. PubMed ID: 8521616
[TBL] [Abstract][Full Text] [Related]
8. Combination effect of a TGF-beta receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Cancer Sci; 2010 Aug; 101(8):1846-52. PubMed ID: 20518790
[TBL] [Abstract][Full Text] [Related]
9. A novel transforming growth factor beta receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma.
Kawajiri H; Yashiro M; Shinto O; Nakamura K; Tendo M; Takemura S; Node M; Hamashima Y; Kajimoto T; Sawada T; Ohira M; Hirakawa K
Clin Cancer Res; 2008 May; 14(9):2850-60. PubMed ID: 18451253
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteomics analysis of gastric cancer stem cells.
Morisaki T; Yashiro M; Kakehashi A; Inagaki A; Kinoshita H; Fukuoka T; Kasashima H; Masuda G; Sakurai K; Kubo N; Muguruma K; Ohira M; Wanibuchi H; Hirakawa K
PLoS One; 2014; 9(11):e110736. PubMed ID: 25379943
[TBL] [Abstract][Full Text] [Related]
11. Role of alpha 2 beta 1- and alpha 3 beta 1-integrin in the peritoneal implantation of scirrhous gastric carcinoma.
Nishimura S; Chung YS; Yashiro M; Inoue T; Sowa M
Br J Cancer; 1996 Nov; 74(9):1406-12. PubMed ID: 8912536
[TBL] [Abstract][Full Text] [Related]
12. Selective cyclooxygenase-2 inhibitor downregulates the paracrine epithelial-mesenchymal interactions of growth in scirrhous gastric carcinoma.
Yashiro M; Nakazawa K; Tendo M; Kosaka K; Shinto O; Hirakawa K
Int J Cancer; 2007 Feb; 120(3):686-93. PubMed ID: 17096355
[TBL] [Abstract][Full Text] [Related]
13. RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility.
Matsuoka T; Yashiro M; Kato Y; Shinto O; Kashiwagi S; Hirakawa K
Clin Exp Metastasis; 2011 Oct; 28(7):627-36. PubMed ID: 21667311
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer.
Kurashige J; Mima K; Sawada G; Takahashi Y; Eguchi H; Sugimachi K; Mori M; Yanagihara K; Yashiro M; Hirakawa K; Baba H; Mimori K
Carcinogenesis; 2015 Jan; 36(1):133-41. PubMed ID: 25411357
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effect of a TGFbeta receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells.
Shinto O; Yashiro M; Kawajiri H; Shimizu K; Shimizu T; Miwa A; Hirakawa K
Br J Cancer; 2010 Mar; 102(5):844-51. PubMed ID: 20145621
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes.
Hippo Y; Yashiro M; Ishii M; Taniguchi H; Tsutsumi S; Hirakawa K; Kodama T; Aburatani H
Cancer Res; 2001 Feb; 61(3):889-95. PubMed ID: 11221876
[TBL] [Abstract][Full Text] [Related]
17. Diffuse-type gastric carcinoma: progression, angiogenesis, and transforming growth factor beta signaling.
Komuro A; Yashiro M; Iwata C; Morishita Y; Johansson E; Matsumoto Y; Watanabe A; Aburatani H; Miyoshi H; Kiyono K; Shirai YT; Suzuki HI; Hirakawa K; Kano MR; Miyazono K
J Natl Cancer Inst; 2009 Apr; 101(8):592-604. PubMed ID: 19351925
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta and hepatocyte growth factor produced by gastric fibroblasts stimulate the invasiveness of scirrhous gastric cancer cells.
Inoue T; Chung YS; Yashiro M; Nishimura S; Hasuma T; Otani S; Sowa M
Jpn J Cancer Res; 1997 Feb; 88(2):152-9. PubMed ID: 9119743
[TBL] [Abstract][Full Text] [Related]
19. Diffuse-type gastric cancer cells switch their driver pathways from FGFR2 signaling to SDF1/CXCR4 axis in hypoxic tumor microenvironments.
Kinoshita H; Yashiro M; Fukuoka T; Hasegawa T; Morisaki T; Kasashima H; Masuda G; Noda S; Hirakawa K
Carcinogenesis; 2015 Dec; 36(12):1511-20. PubMed ID: 26385890
[TBL] [Abstract][Full Text] [Related]
20. Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer.
Iwauchi T; Tanaka H; Yamazoe S; Yashiro M; Yoshii M; Kubo N; Muguruma K; Sawada T; Ohira M; Hirakawa K
Cancer Sci; 2011 Apr; 102(4):683-9. PubMed ID: 21205089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
